A post hoc analysis of patients with T2DM receiving dulaglutide or tirzepatide showed improved biomarkers of MASLD with levels of cytokeratin-18 M30 fragment and procollagen III significantly reduced in patients treated with higher doses of tirzepatide.15 In a retrospective, propensity score matched study from veterans affairs (VA) hospitals in patients with MASLD, treatment with GLP-1RA compared with DPP-4 inhibitors reduced progression to cirrhosis (HR 0.86, 95% CI 0.75 to 0.98), but there was no protective effect in those who had already developed cirrhosis.16 This suggests the timing of treatment needs to be considered, and we also need studies on changes in liver histology with these agents, as this VA trial used clinical and biochemical diagnoses
The numbers matched between semaglutide and placebo groups
Some users split applications between morning and evening for sustained coverage
Why Were Compounded GLP-1 Drugs So Popular
For diabetes control, Ozempic and Rybelsus are comparable when dosed appropriately
Request a consult [email protected] Phone Address 393 Wallace Rd #301 Nashville, TN 37211 Hours M-F: 7:30 am 4:30 pm